Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03475173 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

New Non-invasive Modalities for Assessing Retinal Structure and Function

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. 2 versions Re-verified since Nov 18, 2025, no change to tracked fieldsv9-v10
  2. Primary completion date: Jan 1, 2026 to Jan 1, 2028
    • Study completion date: Mar 1, 2026 to Mar 1, 2028
    v8
  3. Primary completion date: Jan 1, 2024 to Jan 1, 2026
    • Study completion date: Mar 1, 2024 to Mar 1, 2026
    v7
  4. Primary completion date: Jan 1, 2022 to Jan 1, 2024
    • Study completion date: Mar 1, 2022 to Mar 1, 2024
    v6
  5. Primary completion date: Jan 1, 2020 to Jan 1, 2022
    • Study completion date: Jan 1, 2020 to Mar 1, 2022
    v5
Show 3 earlier versionsHide 3 earlier versions
  1. Start date: May 6, 2014 to May 6, 2019v4
  2. Study arms: 0 to 1v3
  3. Eligibility criteria expanded, about 171 wordsv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study investigates a new technology to assess the structure and function inside the eye. Retinal imaging of subjects with inner and outer retinal defects to detect areas of abnormal structure and function compared to other visual function tests.
Trial Details
NCT Number NCT03475173
Lead Sponsor Randy Kardon
Conditions
(from sponsor)		 Ischemic Optic Neuropathy, Branch Retinal Artery Occlusion, Hemianopia, Leber Hereditary Optic Neuropathy, Acute Zonal Occult Outer Retinopathy
Related terms Acute zonal occult outer retinopathy, Hemianopsia, Optic Atrophy, Hereditary, Leber, Optic Nerve Diseases, Optic Neuropathy, Ischemic, Retinal Artery Occlusion, Retinal Diseases
Enrollment 500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov